BrainPhyt is a patented ingredient sourced from the microalgae Phaeodactylum tricornutum and standardized at 2% of fucoxanthin for the support of cognitive health.
Photo © iStockphoto.com/volk65
Microphyt (Baillargues, France) has announced that its flagship ingredient, BrainPhyt, is now Non-GMO Project Verified. BrainPhyt is a patented ingredient sourced from the microalgae Phaeodactylum tricornutum and standardized at 2% of fucoxanthin for the support of cognitive health. The ingredient is produced using the company’s exclusive Camargue technology, the microalgae used to make BrainPhyt is grown in photobioreactors for sustainable and controlled microalgae culture.
"The Non-GMO Project certification is a significant milestone for BrainPhyt and reflects our commitment to providing natural and safe ingredients for consumers," said Christel Lemaire, Microphyt’s marketing manager, in a press release. "We are confident that this certification will further enhance the trust of our customers and partners in the quality and safety of our products."
According to Microphyt, BrainPhyt was recently validated in a human clinical trial, showing that supplementation with the ingredient supports cognitive health in healthy subjects between the ages of 55 and 75. In the study, 66 participants were given either two 275 mg capsules of BrainPhyt or placebo for 24 weeks. Results showed that supplementation with microalgae ingredient improved memory, executive function, attention, and vigilance. The study has not been published.
The impact of GLP-1 on supplements, functional foods, and retail: a webinar from CRN
January 29th 2025The recent CRN webinar discussed GLP-1 medications' impact on supplements, functional foods, and retail, covering consumer trends, global market insights, retailer strategies, industry implications, and future opportunities for innovation.